Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates
Version 3 2024-06-18, 21:46
Version 2 2024-06-04, 15:52
Version 1 2020-07-09, 00:00
A more recent version of this item is available. See latest version
journal contribution
posted on 2020-07-09, 00:00 authored by N Chitranshi, V K Gupta, R Rajput, A Godinez, K Pushpitha, T Shen, M Mirzaei, Y You, D Basavarajappa, Veer GuptaVeer Gupta, S L GrahamEvolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates
History
Related Materials
Location
London, Eng.Publisher DOI
Link to full text
Language
EnglishPublication classification
C1 Refereed article in a scholarly journalJournal
Journal of translational medicineVolume
18Article number
278Pagination
1 - 15ISSN
1479-5876eISSN
1479-5876Issue
1Publisher
BioMed CentralUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC